Live Nasdaq Composite: Markets Take Breather After Impressive Q2 Showing on Easing Oil Outlook
Envista (NVST) Q2 2025 Earnings
Reported Jul 31, 2025 at 4:12 PM ET · SEC Source
Q2 25 EPS
$0.26
BEAT +13.54%
Est. $0.23
Q2 25 Revenue
$682.1M
BEAT +6.53%
Est. $640.3M
vs S&P Since Q2 25
+12.6%
BEATING MARKET
NVST +31.8% vs S&P +19.2%
Market Reaction
Did NVST Beat Earnings? Q2 2025 Results
Envista Holdings delivered a broad-based beat in the second quarter of fiscal 2025, with adjusted diluted EPS of $0.26 coming in 13.54% above the $0.23 consensus estimate and revenue of $682.10 million clearing expectations by 6.53% on 7.7% year-over… Read more Envista Holdings delivered a broad-based beat in the second quarter of fiscal 2025, with adjusted diluted EPS of $0.26 coming in 13.54% above the $0.23 consensus estimate and revenue of $682.10 million clearing expectations by 6.53% on 7.7% year-over-year growth. The dental products company swung to GAAP net income of $26.40 million from a $1.15 billion net loss in the year-ago period, which had been weighed down by a large goodwill and intangible asset impairment charge, while adjusted EBITDA surged 34% to $84.30 million as margin expanded 240 basis points to 12.4%. A key driver was gross margin improvement to 54.2% from 51.6%, fueled by operational gains and continued progress on Spark aligner margins through Envista's internal operating framework. Both the Specialty Products and Equipment segments contributed growth, with core sales rising 4.7% and 7.3%, respectively. Encouraged by first-half momentum, management raised its full-year core sales growth outlook to 3%-4% from 1%-3% and lifted adjusted diluted EPS guidance to $1.05-$1.15, though analysts offered a mixed reaction, lifting revenue forecasts while trimming per-share earnings estimates slightly.
Key Takeaways
- • 5.6% core sales growth across all major businesses and geographies
- • Adjusted EBITDA grew 34% year-on-year to $84 million with 240 bps margin expansion
- • Nobel Biocare returned to positive growth in North America
- • Continued improvement in Spark aligner margins through EBS methodology
- • Gross margin expanded to 54.2% from 51.6% year-over-year
- • Specialty Products & Technologies core sales growth of 4.7%
- • Equipment & Consumables core sales growth of 7.3%
NVST YoY Financials
Q2 2025 vs Q2 2024, source: SEC Filings
NVST Revenue by Segment
With YoY comparisons, source: SEC Filings
“Envista achieved accelerated growth across all of our businesses and major geographies in the second quarter. This allowed us to further increase investments in growth, operations, and people, while also delivering strong improvement in year-over-year profitability. Based on the first half momentum and results, we are raising our full year guidance for 2025.”
— Paul Keel, Q2 2025 Earnings Press Release
NVST Earnings Trends
NVST vs Market 30 Day Price Reactions
30-day stock return vs benchmark after each earnings
NVST EPS Trend
Earnings per share: estimate vs actual
NVST Revenue Trend
Quarterly revenue: estimate vs actual
NVST Quarterly Results
4 quarters of earnings data
| Quarter | EPS Est. | EPS Act. | Surprise | Revenue | Rev. Surprise |
|---|---|---|---|---|---|
| Q1 26 BEAT | $0.31 | $0.36 | +14.94% | $705.5M | +3.74% |
| Q4 25 BEAT FY | $0.32 | $0.38 | +17.65% | $750.6M | +10.39% |
| FY Full Year | — | $1.19 | — | $2.72B | — |
| Q3 25 BEAT | $0.28 | $0.32 | +15.94% | $669.9M | +4.55% |
| Q2 25 BEAT | $0.23 | $0.26 | +13.54% | $682.1M | +6.53% |